Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

COTY

Coty Inc

Feb 17 • 03:47PM ET

2.58

+0.07 2.59 %

Consumer Defensive • Household & Personal Products • USA • NYSE

Peers: EL PG UL NWL KMB CL ENR HAIN CHD HRL

| Held by: VTI IJH VB VBR VDC VXF MDY FNDA IJJ SCHA

Index	-	P/E	-	EPS (ttm)	-0.62	Insider Own	57.86%	Shs Outstand	877.60M	Perf Week	0.98%
Market Cap	2.27B	Forward P/E	6.62	EPS next Y	0.39	Insider Trans	0.07%	Shs Float	370.80M	Perf Month	-18.77%
Enterprise Value	5.50B	PEG	0.25	EPS next Q	0.00	Inst Own	38.35%	Short Float	7.17%	Perf Quarter	-29.06%
Income	-543.40M	P/S	0.39	EPS this Y	36.99%	Inst Trans	2.91%	Short Ratio	3.44	Perf Half Y	-47.66%
Sales	5.81B	P/B	0.64	EPS next Y	29.03%	ROA	-4.65%	Short Interest	26.57M	Perf YTD	-16.39%
Book/sh	4.02	P/C	5.06	EPS next 5Y	26.41%	ROE	-14.50%	52W High	6.13 -57.99%	Perf Year	-53.85%
Cash/sh	0.51	P/FCF	5.80	EPS past 3/5Y	- 19.99%	ROIC	-7.91%	52W Low	2.44 5.54%	Perf 3Y	-76.70%
Dividend Est.	-	EV/EBITDA	6.68	Sales past 3/5Y	3.57% 4.55%	Gross Margin	60.29%	Volatility	5.22% 5.63%	Perf 5Y	-64.53%
Dividend TTM	-	EV/Sales	0.95	EPS Y/Y TTM	-311300.00%	Oper. Margin	6.70%	ATR (14)	0.17	Perf 10Y	-91.11%
Dividend Ex-Date	Feb 14, 2020	Quick Ratio	0.52	Sales Y/Y TTM	-4.65%	Profit Margin	-9.36%	RSI (14)	34.23	Recom	2.90
Dividend Gr. 3/5Y	- -	Current Ratio	0.79	EPS Q/Q	-721.03%	SMA20	-13.72%	Beta	0.96	Target Price	3.53
Payout	-	Debt/Eq	0.97	Sales Q/Q	0.52%	SMA50	-17.29%	Rel Volume	1.07	Prev Close	2.51
Employees	11636	LT Debt/Eq	0.95	Earnings	Feb 05 AMC	SMA200	-37.31%	Avg Volume	7.71M	Price	2.58
IPO	Jun 13, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	-24.12% 1.25%	Trades		Volume	7,961,982	Change	2.59%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-14-26	Resumed	Jefferies	Hold	$3.50
Nov-25-25	Initiated	Rothschild & Co Redburn	Neutral	$3.60
Sep-10-25	Downgrade	Berenberg	Buy → Hold	$5.05
Aug-22-25	Reiterated	RBC Capital Mkts	Sector Perform	$12 → $10
Aug-21-25	Downgrade	Citigroup	Buy → Neutral	$4.25
May-08-25	Downgrade	Canaccord Genuity	Buy → Hold	$5
Apr-17-25	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-15-25	Downgrade	BofA Securities	Buy → Underperform	$4.50
Apr-11-25	Downgrade	Exane BNP Paribas	Outperform → Neutral	$5.65
Mar-27-25	Reiterated	Barclays	Underweight	$6 → $5
Mar-25-25	Initiated	Berenberg	Buy	$7.50
Mar-20-25	Upgrade	Citigroup	Neutral → Buy	$7 → $8
Dec-13-24	Initiated	Goldman	Neutral	$9
Nov-13-24	Downgrade	TD Cowen	Buy → Hold	$11 → $8.50
Nov-07-24	Downgrade	Barclays	Equal Weight → Underweight	$8 → $7
Oct-16-24	Reiterated	Deutsche Bank	Buy	$14 → $12
Oct-07-24	Upgrade	Jefferies	Hold → Buy	$11 → $12
Apr-16-24	Reiterated	Citigroup	Neutral	$13 → $12
Apr-15-24	Initiated	Canaccord Genuity	Buy	$14
Feb-22-24	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $16

Show Previous Ratings

Today 05:16AM	RBC Capital Lowers its Price Target on Coty Inc. (COTY) to $8 and Maintains an Outperform Rating (Insider Monkey)
12:01AM	What Went Wrong at Coty? (WWD)
Feb-13-26 07:12AM	Coty Inc. (COTY) Price Target Cut on Disappointing Quarterly Results and Guidance (Insider Monkey)
Feb-12-26 12:38AM	5 Must-Read Analyst Questions From Coty's Q4 Earnings Call (StockStory)
Feb-09-26 09:15AM	Don't Overlook Coty (COTY) International Revenue Trends While Assessing the Stock (Zacks)
05:16PM	Loading…
Feb-06-26 05:16PM	Analyst Report: Coty Inc. (Morningstar Research) -15.56%
03:45PM	Why Coty (COTY) Stock Is Trading Lower Today (StockStory)
02:20PM	COTY Q4 Deep Dive: Management Focuses on Portfolio Simplification and Channel Shifts Amid Margin Pressure (StockStory)
02:00PM	Coty Inc (COTY) Q2 2026 Earnings Call Highlights: Strategic Shifts and Challenges in Focus (GuruFocus.com)
01:25PM	Tech Bounces As Software Sell-Off Eases, Dow Jones Hits Records: What's Moving Markets Friday? (Benzinga)
08:12AM	Coty Q2 Earnings Miss Estimates Amid Margin Pressure, Revenues Beat (Zacks)
05:29AM	Coty Q2 Earnings Call Highlights (MarketBeat)
12:04AM	Coty Inc (COTY) Q2 2026 Earnings Call Highlights: Strategic Shifts Amid Market Challenges (GuruFocus.com)
Feb-05-26 06:30PM	Compared to Estimates, Coty (COTY) Q2 Earnings: A Look at Key Metrics (Zacks) -8.16%
05:52PM	Coty Swings to Second-Quarter Loss, Withdraws Fiscal-Year Guidance (The Wall Street Journal)
05:45PM	Loading…
05:45PM	Coty (COTY) Q2 Earnings Lag Estimates (Zacks)
05:03PM	Coty Announces Filing of Quarterly Report on Form 10-Q for the Fiscal Quarter Ended December 31, 2025 (Business Wire)
04:51PM	Coty (NYSE:COTY) Surprises With Q4 CY2025 Sales But Stock Drops 14% (StockStory)
04:48PM	Coty: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	Coty Unveils Coty Curated Turnaround Strategy Under Interim CEO Markus Strobel Amid Mixed Q2 Results (WWD)
04:30PM	Coty Announces Second Quarter Fiscal Year 2026 Results (Business Wire)
12:59AM	Coty Inc. Partners With OpenAI to Support Its Global Organizational System (Insider Monkey)
Feb-04-26 05:25PM	e.l.f. Beauty (ELF) Q3 Earnings and Revenues Top Estimates (Zacks) +8.54%
10:00AM	Is Wella Company Going Public? (WWD)
Feb-03-26 10:05PM	Coty Earnings: What To Look For From COTY (StockStory)
11:45AM	Coty Expands AI Capabilities Through Strategic Alliance With OpenAI (Zacks)
11:38AM	Consumer Staples Earnings to Watch This Week: EL, NWL, HSY, COTY, PM (Zacks)
Feb-02-26 11:00AM	Coty's Q2 Earnings on the Horizon: Essential Insights for Investors (Zacks)
08:00AM	Coty Enters Strategic Collaboration With OpenAI to Strengthen Responsible AI Adoption Across the Organization (Business Wire)
Feb-01-26 11:36PM	3 Small-Cap Stocks That Concern Us (StockStory)
02:38AM	Loading…
02:38AM	Where is Coty Inc. (COTY) Headed According to the Street? (Insider Monkey)
Jan-30-26 11:02AM	Is Estee Lauder Stock Worth Buying Ahead of Q2 Earnings Release? (Zacks)
Jan-29-26 10:00AM	Coty (COTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jan-28-26 06:29PM	EXCLUSIVE: Interparfums Inc. Picks Up Licenses for David Beckham, Nautica (WWD)
09:14AM	Can Innovation Unlock Sustained Category Growth for Estee Lauder? (Zacks)
Jan-24-26 05:48AM	TD Cowen Trims Coty Inc. (COTY) Target Ahead of Q4, Keeps Hold Rating (Insider Monkey)
Jan-20-26 11:25AM	Will Coty's Innovation Pipeline Reignite Top-Line Growth? (Zacks)
Jan-19-26 11:17AM	Is Estee Lauder's Skin Care Still a Structural Headwind? (Zacks)
Jan-15-26 12:30PM	Gravity Doesnt Stand A Chance (Business Wire)
Jan-14-26 11:13AM	Coty Inc. (COTY) Exits Wella in a $750 Million Agreement with KKR (Insider Monkey)
09:05AM	Estee Lauder Stock Rises 21.9% in 3 Months: What Should Investors Do? (Zacks)
Jan-12-26 10:11AM	Is Coty (COTY) One of the Cheap Stocks to Buy for the Next 3 Years? (Insider Monkey)
09:33AM	Can Estee Lauder's Fragrance Strength Drive Top-Line Growth? (Zacks)
Jan-07-26 04:45AM	Analysts See Uncertainty Around Coty Inc. (COTY) (Insider Monkey)
Jan-06-26 11:06PM	3 Reasons COTY is Risky and 1 Stock to Buy Instead (StockStory)
10:56AM	EL's North America Trends Improve but Asia Remains the Wild Card (Zacks)
Jan-02-26 10:50AM	S&P Global Ratings Reaffirms BB+ Rating on Coty Inc (COTY) (Insider Monkey)
Dec-30-25 11:20AM	Coty E-Commerce Grows Mid-Single Digits: Is Digital the Backbone? (Zacks)
Dec-29-25 06:21AM	Zacks Industry Outlook Highlights Estee Lauder, Coty, Helen of Troy and European Wax Center (Zacks)
Dec-28-25 12:46PM	BofA Maintains Neutral Stance on Coty (COTY) Heading Into 2026 Amid Uncertain Consumption Growth and Sector-Wide Valuation Disparity (Insider Monkey)
Dec-26-25 10:00AM	Coty Is Speeding Up Its Supply Chain to Turn Around Sagging Sales (The Wall Street Journal)
09:31AM	4 Cosmetics Stocks to Watch as the Market Resets for 2026 (Zacks)
Dec-24-25 11:31PM	3 Out-of-Favor Stocks We Find Risky (StockStory)
Dec-23-25 05:35PM	Evercore ISI cuts Coty to In Line after CEO Nabi stepping down (TipRanks)
11:55AM	Why Coty (COTY) Shares Are Sliding Today (StockStory)
11:17AM	Is ELF's Pricing Strategy Offsetting Tariff-Driven Costs Through 2026? (Zacks)
09:33AM	Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls (The Fly)
09:13AM	Coty taps P&G veteran as CEO but analysts warn of execution risks (Investing.com)
08:13AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: AMETEK, Coty, Janus Henderson, Levi Strauss, Pool Corporation, Southern Copper, and More (24/7 Wall St.)
Dec-22-25 07:21PM	Analyst Report: Coty Inc. (Morningstar Research)
01:32PM	Coty Names P&G Veteran as Interim CEO Amid Beauty Shake-Up (The Wall Street Journal)
05:38AM	Coty Names New Interim CEO Amid Strategic Review (The Wall Street Journal)
02:00AM	Coty Appoints Markus Strobel Executive Chairman and Interim CEO (Business Wire)
Dec-21-25 07:40AM	Coty Completes Wella Divestment to Refocus on Fragrances (Insider Monkey)
Dec-19-25 03:08AM	Coty Divests Remaining Stake in Wella for $750 Million (WWD)
02:00AM	Coty Sells Remaining Stake in Wella to KKR (Business Wire)
Dec-18-25 09:16AM	SBH vs. COTY: Which Stock is Ready to Glam Up Your Portfolio in 2026? (Zacks)
08:40AM	3 Beauty & Cosmetic Stocks Positioned Well for Sustainable Growth (Zacks)
06:32AM	Coty price target lowered to $3.50 from $4.25 at Citi (TipRanks)
Dec-17-25 11:13AM	Can Brand-Led Innovation Sustain ELF's Growth Momentum in FY26? (Zacks)
08:14AM	Why TD Cowen Remains Cautious on Coty Inc. (COTY) (Insider Monkey)
Dec-13-25 10:55AM	JAB plans leadership overhaul at Coty, with chair Harf to step down, FT reports (TipRanks)
Dec-10-25 11:36PM	3 Small-Cap Stocks We Approach with Caution (StockStory)
Dec-09-25 11:30PM	1 Stock Under $10 Worth Investigating and 2 We Ignore (StockStory)
12:28PM	Will Rhode Acquisition Become ELF's Key Growth Catalyst in FY26? (Zacks)
12:20AM	Where is Coty Inc. (COTY) Headed According to Analysts? (Insider Monkey)
Dec-05-25 11:30AM	Why Is Coty (COTY) Down 8.9% Since Last Earnings Report? (Zacks)
Dec-02-25 11:37PM	3 Cash-Producing Stocks We Find Risky (StockStory)
01:44PM	Analyst Report: Coty Inc. (Morningstar Research)
09:23AM	ELF's Gross Margin Falls 165 bps: Are Tariffs the Main Drag Now? (Zacks)
Nov-28-25 08:45AM	Coty Accelerates AI Across Operations: A New Margin Lever? (Zacks)
Nov-25-25 08:06AM	3 Beauty & Cosmetic Stocks Set to Ride on the Next Wave of Growth (Zacks)
Nov-21-25 05:02AM	Coty (COTY) Maintains Strategic Shift Despite Margin Pressures (Insider Monkey)
Nov-20-25 10:34PM	Q3 Rundown: Coty (NYSE:COTY) Vs Other Personal Care Stocks (StockStory)
Nov-17-25 09:15AM	Unlocking Coty (COTY) International Revenues: Trends, Surprises, and Prospects (Zacks)
Nov-13-25 11:37PM	Canaccord Genuity Maintains a Hold on Coty Inc. (COTY) (Insider Monkey)
Nov-12-25 08:02PM	Coty Inc (COTY) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ... (GuruFocus.com) +5.60%
12:33AM	5 Must-Read Analyst Questions From Coty's Q3 Earnings Call (StockStory)
Nov-10-25 06:06AM	COTY STOCK NOTICE: Coty Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law (Newsfile) -5.33%
Nov-07-25 09:34PM	TD Cowen and Canaccord Genuity Maintain Hold Ratings on Coty Inc. (COTY) (Insider Monkey)
02:52PM	Coty Subsidiary Launches Lawsuit Against Kering and Gucci (WWD)
Nov-06-25 04:22PM	Analyst Report: Coty Inc. (Morningstar Research)
04:16PM	Coty Inc (COTY) Q1 2026 Earnings Call Highlights: Navigating Growth Amidst Licensing Challenges (GuruFocus.com)
11:32AM	Coty's Q1 Earnings Miss Estimates, Revenues Decline 6% Y/Y (Zacks)
Nov-05-25 07:30PM	Compared to Estimates, Coty (COTY) Q1 Earnings: A Look at Key Metrics (Zacks)
06:15PM	Coty (COTY) Q1 Earnings and Revenues Lag Estimates (Zacks)
05:13PM	Coty: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
05:05PM	Coty's (NYSE:COTY) Q3 Earnings Results: Revenue In Line With Expectations, Stock Jumps 10.7% (StockStory)
04:47PM	Coty Sees Sales Slip in Q1 as Gucci License Loss Looms (WWD)
04:30PM	Coty Reports In Line Q1 Results, with Q2 Sales Tracking Toward the More Favorable End of Prior Guidance; Expects a Return to Growth in 2H FY26 (Business Wire)

Coty, Inc. engages in the manufacture, market, sale, and distribution of branded beauty products. It operates through the following segments: Prestige, Consumer Beauty, and Corporate. The company was founded by Francois Coty in 1904 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mercier Laurent	Chief Financial Officer	Oct 19 '25	Option Exercise	0.00	210,526	0	615,742	Oct 21 06:52 PM
Nabi Sue	Chief Executive Officer	Sep 01 '25	Option Exercise	0.00	1,562,500	0	33,689,786	Sep 03 07:02 PM
Blazewicz Kristin	Chief Legal Officer	Sep 03 '25	Buy	4.30	29,400	126,532	829,142	Sep 03 07:00 PM
Mercier Laurent	Chief Financial Officer	Aug 25 '25	Buy	3.96	12,500	49,500	402,216	Aug 28 06:30 PM
Mercier Laurent	Chief Financial Officer	Aug 26 '25	Buy	3.84	3,000	11,517	405,216	Aug 28 06:30 PM
Srinivasan Priya	Chief People & Purpose Officer	Aug 22 '25	Buy	3.84	30,000	115,200	37,509	Aug 26 06:53 PM
Nabi Sue	Chief Executive Officer	Aug 22 '25	Buy	3.92	260,000	1,018,160	32,127,286	Aug 26 06:49 PM

Peers: JNJ PFE MRK BMY LLY NVS AZN-D ABBV SNY GILD

| Held by: PPH AVDE FENI FVD RODM AVIV DFAX GMOI AQEC BINV

Index	-	P/E	16.63	EPS (ttm)	3.66	Insider Own	0.00%	Shs Outstand	2.04B	Perf Week	3.25%
Market Cap	122.90B	Forward P/E	11.43	EPS next Y	5.33	Insider Trans	-	Shs Float	2.02B	Perf Month	24.04%
Enterprise Value	141.59B	PEG	1.79	EPS next Q	1.17	Inst Own	19.31%	Short Float	0.88%	Perf Quarter	26.57%
Income	7.53B	P/S	2.85	EPS this Y	2.85%	Inst Trans	0.82%	Short Ratio	3.65	Perf Half Y	54.80%
Sales	43.11B	P/B	5.64	EPS next Y	10.28%	ROA	9.61%	Short Interest	17.72M	Perf YTD	24.25%
Book/sh	10.81	P/C	26.83	EPS next 5Y	6.39%	ROE	38.48%	52W High	60.37 0.93%	Perf Year	68.45%
Cash/sh	2.27	P/FCF	15.60	EPS past 3/5Y	-25.93% 0.08%	ROIC	18.01%	52W Low	32.38 88.17%	Perf 3Y	69.82%
Dividend Est.	1.93 (3.16%)	EV/EBITDA	9.86	Sales past 3/5Y	6.03% -0.31%	Gross Margin	72.53%	Volatility	1.56% 1.70%	Perf 5Y	66.63%
Dividend TTM	1.71 (2.80%)	EV/Sales	3.28	EPS Y/Y TTM	132.14%	Oper. Margin	22.57%	ATR (14)	1.23	Perf 10Y	51.91%
Dividend Ex-Date	Feb 20, 2026	Quick Ratio	0.54	Sales Y/Y TTM	7.51%	Profit Margin	17.47%	RSI (14)	78.51	Recom	2.83
Dividend Gr. 3/5Y	8.77% -7.68%	Current Ratio	0.82	EPS Q/Q	61.53%	SMA20	12.40%	Beta	0.46	Target Price	56.10
Payout	47.15%	Debt/Eq	1.08	Sales Q/Q	10.17%	SMA50	19.08%	Rel Volume	1.00	Prev Close	58.93
Employees	68629	LT Debt/Eq	0.90	Earnings	Feb 04 BMO	SMA200	39.75%	Avg Volume	4.86M	Price	60.93
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.50% 3.23%	Trades		Volume	4,711,850	Change	3.39%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Initiated	Citigroup	Neutral
Jan-06-26	Downgrade	Barclays	Equal Weight → Underweight
Nov-25-25	Upgrade	BofA Securities	Underperform → Neutral
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight

Show Previous Ratings

Today 06:31AM	Europe Clears GSK's New Twice-Yearly Asthma Treatment (Benzinga)
Feb-15-26 09:10AM	GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17% (Insider Monkey)
Feb-13-26 10:59AM	Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms (Benzinga)
09:36AM	Can Gilead's HIV Portfolio Sustain Its Growth Trend in 2026? (Zacks)
Feb-11-26 10:15AM	GILD's Q4 Earnings Beat Estimates, HIV and Liver Disease Drugs Power Sales (Zacks)
07:15AM	Loading…
Feb-09-26 07:15AM	Citi lifts GSK target price but keeps neutral stance after rally (Proactive)
Feb-06-26 11:45AM	GSK Gets EU Approval for Expanded Use of Nucala in COPD (Zacks)
05:15AM	ShoreCap says GSK has cracked it and the £40bn prize is now in sight (Proactive)
Feb-05-26 09:15AM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q4 Earnings? (Zacks)
02:04AM	Analyst Report: GSK plc (Morningstar Research)
Feb-04-26 09:00PM	Analyst Report: GSK plc (Morningstar Research) +7.29%
04:05PM	GSK Is Eyeing $55 Billion In Sales And It Has Nothing To Do With Obesity (Investor's Business Daily)
01:52PM	GSK Shares Jump 5.2% as New CEO Signals Faster R&D, Deal Push (GuruFocus.com)
01:50PM	GSK Beats Estimates, Sticks With Long-Term Outlook (GuruFocus.com)
12:01PM	GSK PLC (GSK) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic ... (GuruFocus.com)
10:30AM	Loading…
10:30AM	GSK beat the numbers, but the real story was the guidance (Proactive)
08:31AM	GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook (Zacks)
08:12AM	GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike (Benzinga)
07:27AM	GSK Q4 Earnings Call Highlights (MarketBeat)
07:05AM	GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
02:45AM	GSKs Specialty Medicines Drive Solid Results (The Wall Street Journal)
02:20AM	Glaxo: Q4 Earnings Snapshot (Associated Press Finance)
Feb-03-26 12:30PM	Wave Life Sciences price target raised to $50 from $47 at Clear Street (TipRanks)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
07:17AM	GSK PLC (LSE:GSK) Q4 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Feb-02-26 02:16PM	Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path (Benzinga)
10:01AM	AstraZeneca Shares Start Trading in US After Listing Upgrade (Bloomberg)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-29-26 10:00AM	Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for (Zacks)
10:00AM	Loading…
Jan-28-26 10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
05:51AM	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle (Benzinga)
Jan-27-26 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
Jan-22-26 01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-21-26 10:23AM	GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout (Zacks)
10:00AM	GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026 (Business Wire)
Jan-20-26 05:30PM	Why Rapt Therapeutics Stock Soared Today (Motley Fool)
04:05PM	GSK Digs In On Allergies With $2.2 Billion Rapt Therapeutics Buyout (Investor's Business Daily)
01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
09:36AM	Stocks to Watch Tuesday: 3M, Nvidia, Netflix, Warner Bros. (The Wall Street Journal)
09:00AM	GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million (Business Wire)
07:10AM	This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. (Barrons.com)
05:54AM	GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough (Benzinga)
Jan-15-26 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
08:53AM	Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week? (Zacks)
Jan-12-26 01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
09:45AM	Why GSK (GSK) is a Top Growth Stock for the Long-Term (Zacks)
06:15AM	Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSKs B7-H3 Antibody Drug Conjugate (ADC) (Business Wire)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
Jan-10-26 02:57PM	Jefferies Reaffirms a Buy Rating on GSK plc (GSK) - Here's Why (Insider Monkey)
Jan-09-26 01:56PM	AnaptysBio Pushes Back Against Lawsuit Over Cancer Drug Jemperli Royalties (Benzinga)
05:10AM	Johnson & Johnson Strikes Deal With White House to Lower Drug Prices (Barrons.com)
Jan-08-26 12:33PM	GSK's Chronic Hepatitis B Drug Meets Goals in Two Late-Stage Studies (Zacks)
Jan-07-26 10:50AM	GSK Scores Phase III Win in Hep B (GuruFocus.com)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jan-06-26 12:48PM	GSK Wins Japan Approval for Exdensur (GuruFocus.com)
11:12AM	MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine (Zacks)
Jan-05-26 02:38PM	Flu Season's Here-This Dividend-Payer Controls the Shot Market (MarketBeat)
Dec-31-25 11:03AM	Pfizer and GSK Lead 2026 U.S. Drug Price Hikes (GuruFocus.com)
09:34AM	Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs (GuruFocus.com)
Dec-30-25 09:40AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
Dec-29-25 11:59PM	Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? (Insider Monkey)
03:28AM	HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target (Insider Monkey)
Dec-24-25 10:33AM	Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know (Zacks)
Dec-22-25 08:27AM	Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals (Zacks)
Dec-19-25 04:46PM	Trump reaches deal with 9 drug companies to lower prices (Yahoo Finance Video)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:09PM	More Drugmakers Reach Deals With White House to Lower Prices (The Wall Street Journal)
02:50PM	Nine Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
02:50PM	More Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
12:15PM	Pharma's $370B Bet on America: The ETF Plays for 2026 (Zacks)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
08:12AM	Will GILD's Strong HIV Portfolio Reap Rewards in 2026? (Zacks)
Dec-18-25 10:41AM	Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026? (Zacks)
07:41AM	GSK Gains FDA Approval for Exdensur in Severe Eosinophilic Asthma (GuruFocus.com)
07:27AM	GSK's Asthma Drug Gets U.S. Greenlight--$4 Billion Blockbuster in the Making? (GuruFocus.com)
Dec-17-25 10:29AM	GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment (Zacks)
09:45AM	Share Offerings Prompt Huge Insider Buying in These 3 Biotechs (24/7 Wall St.)
Dec-16-25 09:55PM	Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma (Business Wire)
08:53AM	GILD's Bictegravir and Lenacapavir Regimen for HIV Meets Primary Goal (Zacks)
Dec-15-25 10:49AM	FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer (Zacks)
10:27AM	GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU (Zacks)
Dec-12-25 01:53PM	GSK's $4 Billion Asthma Drug Gets First-Ever Green Light in Europe (GuruFocus.com)
10:08AM	GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea (Zacks)
07:28AM	GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation (Insider Monkey)
03:00AM	US is best place to invest, says boss of British drugs giant (The Telegraph)
Dec-11-25 11:03AM	GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer (Zacks)
09:12AM	GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell? (Zacks)
Dec-10-25 11:28AM	J.P. Morgan Maintains a Sell Rating on GSK plc (GSK) (Insider Monkey)
09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Dec-09-25 09:10AM	How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks (Zacks)
Dec-04-25 11:30AM	Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-03-25 09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Dec-02-25 09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
Dec-01-25 04:21PM	Top Analyst Reports for Palantir, Philip Morris & TotalEnergies (Zacks)
Nov-25-25 07:22PM	U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs (The Wall Street Journal)
04:14AM	BofA upgrades Novartis and GSK as pivotal data, new launches approach (Investing.com)
Nov-21-25 04:46PM	AnaptysBio Reverses Higher After Trading Legal Barbs With Pharma Giant GSK (Investor's Business Daily)
02:37PM	Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. (Investor's Business Daily)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Dec 11 '25	Buy	19.00	1,470,000	27,930,000	18,245,691	Dec 15 04:32 PM

COTY

Coty Inc

GSK

GSK Plc ADR

Upgrade your FINVIZ experience